The company remains in a pre-revenue phase, reporting zero revenue alongside an escalating SG&A expense burden that reached $1.9 million in 2026Q1.
| Net Interest Income | 6.62M | 9.72M | 317.27K |
| NII Growth % | 616.33% | 2964.07% | - |
| Net Interest Margin % | 2.72% | 4.03% | 0.16% |
| Interest Income | 6.62M | 9.72M | 317.27K |
| Interest Expense | 0 | 0 | 0 |
| Loan Loss Provision | 0 | 0 | 0 |
| Non-Interest Income | -6.62M | -9.72M | -317.27K |
| Non-Interest Income % | - | - | - |
| Total Revenue | 0 | 0 | 0 |
| Revenue Growth % | 0% | - | - |
| Non-Interest Expense | 3.35M | 2.25M | 206.94K |
| Efficiency Ratio | - | - | - |
| Operating Income | -3.35M | -2.25M | -207K |
| Operating Margin % | - | - | - |
| Operating Income Growth % | - | -988.23% | - |
| Pretax Income | 3.65M | 7.74M | 223.46K |
| Pretax Margin % | - | - | - |
| Income Tax | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% |
| Net Income | 3.65M | 7.74M | 223.46K |
| Net Margin % | - | - | - |
| Net Income Growth % | - | 3362.54% | - |
| Net Income (Continuing) | 3.65M | 7.74M | 223.46K |
| EPS (Diluted) | 0.16 | 0.34 | 0.01 |
| EPS Growth % | - | - | - |
| EPS (Basic) | - | 0.34 | 0.01 |
| Diluted Shares Outstanding | 23M | 22.78M | 27.67M |
Imminent Liquidation Deadline Risk
As reported in recent financial filings, DRDBW's SG&A expenses surged to $1.9 million in 2026Q1, reflecting a significant increase from the $90.7 thousand recorded in 2024Q3, which suggests rising operational costs as the company approaches its critical business combination deadline within a constrained liquidity environment.
The sharp rise in SG&A expenses indicates that the costs associated with maintaining the public listing and pursuing a target are accelerating. This trend warrants close monitoring, as the company lacks operational revenue to offset these expenditures, forcing an increased reliance on sponsor-provided capital.
Based on the company's income statements, net income volatility is driven by non-operating items rather than core operations, evidenced by the $1.4 million profit in 2025Q4 despite zero revenue, which likely reflects mark-to-market adjustments on warrant liabilities rather than genuine underlying business performance.
Investors should be cautious when interpreting these net income figures, as they do not represent operational success. The accounting treatment of warrants under ASC 815-40 creates artificial swings in profitability that mask the underlying cash burn inherent in the SPAC's pre-combination phase.
According to the provided quarterly data, DRDBW continues to report operating losses, with 2026Q1 showing an operating loss of $1.9 million, confirming that the company has yet to achieve any form of operational scale or efficiency as it remains in the pre-merger search phase.
The absence of revenue means that every dollar spent on SG&A directly expands the operating loss, highlighting the lack of operating leverage. This structure implies that the company's financial viability is entirely dependent on the successful execution of a merger rather than internal cost management.
As indicated by the company's 2021 incorporation date and current cash position of $183,022, there is a heightened risk that the vehicle may fail to secure a target, potentially leading to the expiration of warrants, which investors should view as a binary outcome rather than a traditional equity investment.
The market may be mispricing the warrants by failing to account for the high probability of liquidation if a deal is not finalized soon. The limited cash reserves suggest that the sponsor's ability to fund the search is reaching a critical inflection point, increasing the likelihood of a value-destructive outcome for warrant holders.
Quick answers to the most common questions about buying DRDBW stock.
Roman DBDR Acquisition Corp. II (DRDBW) is profitable, generating $7.7M in net income for the fiscal year ending 2025.